EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Nationwide Short-Term and Midterm Clinical Outcome Comparison of Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Surgery

Monica Gianoli iD, Anne R de Jong, Ferenc van der Hulst, Maaike M Roefs, Sandeep Singh, Patrique Segers, Pim van der Harst, Willem J L Suyker, Kirolos A Jacob

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery · 2026-03 · 21 (2) · 150-158

DOI: 10.1177/15569845261437076 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, online erschienen am 23.04.2026. Verfasst von Monica Gianoli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Heart and Lungs Division, Cardiothoracic Department, University Medical Center Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Coronary Artery Bypass, Off-Pump, Coronary Artery Disease, Myocardial Revascularization. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Hybrid coronary revascularization (HCR) has emerged as a minimally invasive alternative to conventional coronary artery bypass techniques for patients with multivessel coronary artery disease. This study aimed to compare the clinical outcomes of HCR versus off-pump coronary artery bypass (OPCAB) in patients with multivessel disease in The Netherlands.

Methods

This study analyzed 117 HCR patients and 313 OPCAB patients after propensity score matching. The primary outcome was the incidence of major adverse cardiac and cerebrovascular events (MACCE) at 30 days after the procedure. Secondary outcomes included mortality, myocardial infarction, repeat revascularization, and ischemic cerebrovascular accidents. Midterm survival and repeat target vessel revascularization (TVR) were evaluated over a median follow-up of 36 months.

Results

At 30 days, MACCE rates were similar between the HCR group (5.1%) and the OPCAB group (4.1%; P = 0.62). Secondary outcomes were also comparable between the groups. The incidence of myocardial infarction in the HCR group was numerically higher (3.4% vs 1.6%), but this difference was not statistically significant ( P = 0.17). Midterm survival rates showed no significant difference between the groups, although numerically the HCR showed a higher rate of TVR (5.1% vs 4.1%, P = 0.62). No significant differences were found in blood transfusion requirements or postoperative hospital stay duration.

Conclusions

HCR demonstrated comparable short-term and midterm outcomes to OPCAB, suggesting it is a viable alternative for multivessel coronary artery disease treatment. However, further research is necessary to assess long-term effectiveness and to identify specific patient populations who may benefit most from HCR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery Bypass, Off-PumpCoronary Artery DiseaseMyocardial RevascularizationHumansFemaleMaleTreatment OutcomeAgedNetherlandsMiddle AgedPostoperative ComplicationsPropensity ScoreRetrospective StudiesMyocardial Infarction

Stichwörter der Autor:innen

hybrid revascularizationminimal invasive cardiac surgeryoff-pump coronary artery bypassrobotic-assisted MIDCAB

Autor:innen und Institutionen

  • Heart and Lungs Division, Cardiothoracic Department, University Medical Center Utrecht, The Netherlands.
  • Netherlands Heart Registration, Utrecht, The Netherlands.
  • Cardiothoracic Department, Isala Clinics, Zwolle, The Netherlands.
  • Cardiothoracic Department, Maastricht University Medical Center, The Netherlands.
  • Heart and Lungs Division, Cardiology Department, University Medical Center Utrecht, The Netherlands.

ORCID-Profile: Monica Gianoli

Zitieren

APA

Gianoli, M., de Jong, A. R., van der Hulst, F., Roefs, M. M., Singh, S., Segers, P., van der Harst, P., Suyker, W. J. L., & Jacob, K. A. (2026). Nationwide Short-Term and Midterm Clinical Outcome Comparison of Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Surgery. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 21(2), 150-158. https://doi.org/10.1177/15569845261437076

Vancouver

Gianoli M, de Jong AR, van der Hulst F, Roefs MM, Singh S, Segers P, et al. Nationwide Short-Term and Midterm Clinical Outcome Comparison of Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Surgery. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2026;21(2):150-158. doi:10.1177/15569845261437076

BibTeX
@article{Gianoli2026,
  author = {Gianoli, Monica and de Jong, Anne R and van der Hulst, Ferenc and Roefs, Maaike M and Singh, Sandeep and Segers, Patrique and van der Harst, Pim and Suyker, Willem J L and Jacob, Kirolos A},
  title = {Nationwide Short-Term and Midterm Clinical Outcome Comparison of Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Surgery},
  journal = {Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery},
  year = {2026},
  volume = {21},
  number = {2},
  pages = {150--158},
  doi = {10.1177/15569845261437076}
}
Kostenlos starten →